Blood-based gels battle diabetic foot ulcers in head-to-head trial
NCT ID NCT05979584
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two treatments made from patients' own blood—platelet-rich plasma and platelet-fibrin plasma—to see which works better for healing diabetic foot ulcers. 56 adults with diabetes and slow-healing foot wounds were randomly assigned to receive one of the treatments plus standard care. The main goal was to compare how many wounds healed within 4 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University 3rd Hospital
Beijing, Beijing Municipality, 010, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves and nanoparticles join forces to heal diabetic foot wounds
- Smartphone app could let diabetic foot ulcer patients skip clinic visits for wound checks
- Placenta power: could donor cells heal diabetic foot wounds?
- Pig liver scaffold may speed healing of stubborn diabetic wounds
- Could soundwaves heal diabetic foot ulcers faster?
- Custom 3D printed insoles may help diabetic patients avoid foot ulcers